Yellow filters for the eye have been of interest to ophthalmologists and optometrists for the last 30 years. Certain fish species can change the colour of the cornea in response to the level of illumination and regulate the amount of short-wavelength light reaching the retina. A positive influence of yellow eye filters on reduction of chromatic aberration has been found in a fish eye model. Blue-light-filter (yellow) intraocular lenses (IOLs) were introduced for cataract surgery almost 20 years ago. The main advantage of yellow IOLs is thought to be the reduction of chromatic aberration under photopic conditions and protection of the retina from phototoxic short-wavelength light, especially in eyes at risk of age-related macular degeneration (AMD). This article highlights the importance of yellow IOLs for cataract surgery in terms of quality of vision and AMD protection.
The fact that short-wavelength blue light has a phototoxic effect on the retina was discovered in the late 1970s. [1] [2] [3] It is known that certain fish species change the colour of their corneas in response to the level of illumination and regulate the amount of short-wavelength light reaching the retina. 4 It was further proposed that this phenomenon might also have a positive influence on visual quality by reducing longitudinal chromatic aberration. [4] [5] [6] This led to the development of yellow-tinted intraocular lenses (IOLs) for cataract surgery in the early 1990s. 7 These
IOLs, first developed and produced by Hoya Healthcare Corporation, Japan, did not become popular until recent years, when Alcon in the US started a big marketing campaign to relaunch these IOLs worldwide.
There is no doubt about the importance of ultraviolet (UV) blockers in
IOLs, but there is still a lot of discussion about the usefulness of filtering short-wavelength blue light with IOLs. People advocating these IOLs argue that they might protect the retina from phototoxic damage and increase visual quality by reducing chromatic aberration.
Surgeons refusing to use the lens are worried about mesopic and scotopic contrast and colour sensitivity. This article highlights the pros and cons of blue-light-filter yellow IOLs.
comparison with cells protected with blue-light filters. Pigmented rabbits were exposed to xenon light, with one eye of the animal protected by a yellow filter and the other eye by a UV filter.
Electrophysical measurements showed significantly higher cell damage of the neuroretina and RPE functions in the eyes with the UV filter compared with the eyes with blue-light filters. Blue-light-filtering IOLs were introduced in cataract surgery in the 1990s as there were data suggesting improvements in clarity of vision, contrast acuity and reaction time, as well as reduced glare.
In addition to filtering UV light, they absorb a larger part of the highenergy visible blue light between approximately 380 and 500nm. In recent years, these IOLs have experienced a renaissance due to some evidence for visible blue light being a contributing factor to apoptosis of human RPE cells, and therefore blue-light-filtering IOLs may have a positive impact on AMD. 18 Another study reported on an inhibitory effect of blue-light-filtering IOLs on vascular endothelial growth factor, which is one of the pro-angiogenetic factors in the pathogenesis of exudative AMD. 19 Nowadays, the age of patients undergoing cataract surgery is decreasing, which is inversely proportional to life expectancy and therefore elongates the period of pseudophakia. Furthermore, the acceptance of refractive lens exchange is growing. This implies a potential long-term effect or even a cumulative effect of short-wavelength visible light and its possible consequences.
Even so, there is no definite proof of the positive effect of filtering toxic short-wavelength light via yellow IOLs. However, there is some clinical and investigative evidence that such an IOL might be useful in reducing the risk of AMD in pseudophakic eyes.
Visual Performance with Blue-light-filter Intraocular Lenses

Theoretical Background
The hypothesis that filtering blue light might increase visual performance was first suggested in the 1970s. 6 Protagonists of these lenses argued that such an IOL would increase visual quality by reducing longitudinal chromatic aberration, which is three times higher with clear UV-blocking IOLs compared with the crystalline lens. 20 Opponents of blue-light-filter IOLs argue that these lenses might have a negative influence on the scotopic and mesopic contrast sensitivity due to the Purkinje shift, since blue light is much more important for scotopic than for photopic vision. The scotopic luminous efficiency peak, mainly contributed to by rods, is at 507nm, whereas photopic luminous efficiency peak is at 555nm, mainly contributed to by cones. 21 Blocking blue light up to 500nm should theoretically result in a decrease in mesopic vision. 23 and UV transmission spectrum depending on the IOL material used. There was a significant difference between hydrophilic and hydrophobic acrylic materials. 23 Mainster actually propagates implantation of orange IOLs to filter violet instead of blue light. This would protect the retina from the phototoxic short wavelengths between 400 and 440nm and transmit blue light of more than 440nm for better scotopic vision. 21, 24, 25 However, the orange IOL has been shown to have a transmission spectrum of less than 60% at 500nm, whereas the yellow IOLs have a transmission spectrum of 80-90% at 500nm. The crystalline lens of a 53-year-old person shows a transmission spectrum of 70% at 500nm and so, in theory, scotopic vision should actually be better with yellow IOLs in pseudophakic patients than in the phakic eye of a 53-year-old patient.
23,26
Clinical Evidence
The first clinical study on yellow IOLs was published in 1996, 22 but a high number of clinical studies have been published since on bluelight-filter IOLs with a special focus on the visual quality of the patients.
There is general agreement that yellow IOLs do not have any significant negative impact on visual acuity, photopic contrast performance and colour sensitivity. 22, [27] [28] [29] [30] [31] Some studies actually showed better contrast sensitivity with yellow rather than with clear IOLs, 22 especially in patients with diabetes. 27, 30 which is also the experience of the authors. 27 However, these studies are poorly comparable, since different tests were used to examine contrast included patients in the study only if they had an IOL power of +21.00 to +22.5D, 30, 32 other studies report on IOLs implanted between +10 and + 30D. 29 However, the transmittance capacity of the IOLs also depends on the IOL power, and the published data are given for a +21D IOL. 
